A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia

Clinical Infectious Diseases

Volumn 62, Issue , 2016, Pages S175-S182

  Beres, Laura K ^a,b   Tate, Jacqueline E ^c   Njobvu, Lungowe ^a   Chibwe, Bertha ^a   Rudd, Cheryl ^a   Guffey, M Brad ^a   Stringer, Jeffrey S A ^d   Parashar, Umesh D ^c   Chilengi, Roma ^a  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

immunization; rotavirus; rotavirus vaccine; vaccine effectiveness; Zambia

Indexed keywords

ROTAVIRUS VACCINE; VIRUS ANTIGEN; LIVE VACCINE; RIX4414 VACCINE; VACCINE;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; ENZYME IMMUNOASSAY; FECES ANALYSIS; FEMALE; GROUPS BY AGE; HOSPITALIZATION; HUMAN; INFANT; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS INFECTION; VIRUS DETECTION; ZAMBIA; DIARRHEA; FECES; IMMUNOLOGY; NEWBORN; ODDS RATIO; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; VACCINATION; VACCINE IMMUNOGENICITY; VIROLOGY;

ANTIGENS, VIRAL; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DIARRHEA; FECES; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOGENICITY, VACCINE; INFANT; INFANT, NEWBORN; MALE; ODDS RATIO; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEVERITY OF ILLNESS INDEX; VACCINATION; VACCINE POTENCY; VACCINES, ATTENUATED; ZAMBIA;

EID: 84965101403     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1206     Document Type: Article

References (19)

1. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151-61.
2. United Nations Children's Fund/World Health Organization. Diarrhoea: why children are still dying and what can be done. Geneva, Switzerland: WHO, 2009.
3. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136-41.
4. Ministry of Health, Zambia. 2008 annual health statistical bulletin. Lusaka, Zambia: Ministry of Health, 2009.
5. Steele AD, Kasolo FC, Bos P, Peenze I, Oshitani H, Mpabalwani E. Characterization of VP6 subgroup, VP7 and VP4 genotype of rotavirus strains in Lusaka, Zambia. Ann Trop Paediatr 1998; 18:111-6.
6. Mwenda JM, Ntoto KM, Abebe A, et al. Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance Network. J Infect Dis 2010; 202(suppl):S5-11.
7. Gavi, the Vaccine Alliance. Rotavirus vaccine support. Available at: http://www. gavi.org/support/nvs/rotavirus/. Accessed 4 September 2015.
8. Paternina-Caicedo A, Parashar UD, Alvis-Guzman N, et al. Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries. Vaccine 2015; 33:3923-8.
9. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98.
10. Bar-Zeev N, Kapanda L, Tate JE, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and casecontrol study. Lancet Infect Dis 2015; 15:422-8.
11. Groome MJ, Page N, Cortese MM, et al. Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: A case-control study. Lancet Infect Dis 2014; 14:1096-104.
12. Chilengi R, Rudd C, Bolton C, et al. Successes, challenges and lessons learned in accelerating introduction of rotavirus immunisation in Zambia. World J Vaccines 2015; 5:43-53.
13. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63.
14. Jiang V, Jiang B, Tate J, Parashar UD, Patel MM. Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin 2010; 6:532-42.
15. Soares-Weiser K, Goldberg E, Tamimi G, Pitan OC, Leibovici L. Rotavirus vaccine for preventing diarrhoea. Cochrane Database Syst Rev 2004:CD002848.
16. Linhares AC, Lanata CF, Hausdorff WP, Gabbay YB, Black RE. Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea. Pediatr Infect Dis J 1999; 18:1001-6.
17. Mpabalwani M, Oshitani H, Kasolo F, et al. Rotavirus gastro-enteritis in hospitalized children with acute diarrhoea in Zambia. Ann Trop Paediatr 1995; 15:39-43.
18. Soares-Weiser K, Maclehose H, Bergman H, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2012; 11:CD008521.
19. Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009; 200(suppl 1):S39-48.